Skip to search formSkip to main contentSkip to account menu

Racivir

Known as: 2',3',5-FTC, 2',3'-dideoxy-5-fluoro-3'-thiacytidine, 5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

Antiviral AgentsZalcitabine

Narrower (1)

BW 524W91
Hividanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities.
Review
2004
Review
2004
New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
  • M. Otto
  • Current opinion in pharmacology (Print)
  • 2004
  • Corpus ID: 23293362
1994
1994
Pharmacokinetics of 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats.
Although several drugs have shown clinical anti-human immunodeficiency virus activity, reduced activity with long-term use and… 
Highly Cited
1992
Highly Cited
1992
Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2',3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) and related compounds
Racemic 2',3'-dideoxy-3'-thianucleosides were resolved by enzyme-catalyzed hydrolysis of their butyrate ester derivatives 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)